Industry 4.0: Where are we, and how to accelerate the transition?
Strategies to faster implement pharma 4.0 concepts in biopharmaceutical industry using advanced data storing platform and hybrid modeling
Are you interested in a summary of our latest research results, scientific statements, a report about an event or simply about our team excursions? Read​ more about all these topics in our most recent posts.
Industry 4.0: Where are we, and how to accelerate the transition?
Reduced experimental burden in CHO process development across scale: hybrid modeling and iDoE
How to predict continuous ultrafiltration from batch experiments
Advanced online sensors for monitoring and modeling of HEK 293 gene therapy processes
Antleron and Novasign to join forces in ATMP Modeling
One recipe for all
Novasign Soft Sensing Technology at Siemens’ LivingLab
The Future of Bioprocess Development - A Panel Discussion with Leading Experts
Intensified DoE and hybrid modeling accelerate upstream process characterization
Hybrid Models facilitate Scale-Up and Digital Twins for tangential flow filtration
COVID-19: An example of why we need robust and fast process development
COVID-19, home office and a new toolbox release
The Hybrid Modeling Summer School 2019
Beyond static process descriptions
Novasign at the Vienna City Marathon 2019